Forbes: Petrochemical CEO shows most value

Eran Schwartz, CEO of Israel Petrochemical Enterprises, was the only one of last year's top three who featured in the 2006 list.

October 23, 2006 07:14
forbes biz 88 298

forbes biz 88 298. (photo credit: Courtesy photo)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Israel's top management was highlighted by Forbes this week when the magazine released its best performers for 2006 with some of the underdogs proving their worth to their businesses. Eran Schwartz, CEO of Israel Petrochemical Enterprises, was the only one of last year's top three who featured in the 2006 list, proving to be the manager who showed the highest return of investment relative to his salary. Israel Chemicals' Akiva Mozes and property company Alrov's Alfred Akirov followed in second and third places, respectively, while the CEOs of Jerusalem Economic Corp. and Ormat filled out the better half of the top-10 list. They were followed by the CEOs of Apax Partners Israel, Excellence, Gav Yam Bayside Land Corp., Alony Hetz and Africa-Israel to complete the list. Absent from the rankings this year, Forbes noted, was Shlomo Yanai, Teva Pharmeceutical Industries' controversial new choice for CEO, who last year took ninth place as CEO of Makhteshim Agan. Forbes took into account the excess yield earned by the companies relative to the TA 100; their return versus that achieved by the industry in which they operate; and the salary of the managers through 2004 and 2005.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection